Phagocytosis of apoptotic inflammatory cells by microglia and modulation by different cytokines: Mechanism for removal of apoptotic cells in the inflamed nervous system
A. Chan et al., Phagocytosis of apoptotic inflammatory cells by microglia and modulation by different cytokines: Mechanism for removal of apoptotic cells in the inflamed nervous system, GLIA, 33(1), 2001, pp. 87-95
Apoptosis of autoaggressive T cells in the central nervous system (CNS) is
an effective, nonphlogistic mechanism for the termination of autoimmune inf
lammation in experimental autoimmune encephalomyelitis (EAE). The clearance
of apoptotic leukocytes by tissue-specific phagocytes is a critical event
in the resolution of the inflammatory attack. To investigate the role of mi
croglia in the removal of apoptotic cells and potential regulatory mechanis
ms of microglial phagocytosis, an in vitro phagocytosis assay was establish
ed, using Lewis rat microglia. Microglia exhibited a high capacity for the
uptake of apoptotic autologous thymocytes, as well as apoptotic encephalito
genic myelin basic protein (MBP)-specific T cells, in contrast to nonapopto
tic target cells. Pretreatment of microglia with interferon-gamma (IFN-gamm
a) raised the proportion of microglia capable of phagocytosing apoptotic ce
lls to 75% above the untreated controls. The increased phagocytic activity
was selective for apoptotic target cells and was not dependent on phosphati
dylserine-mediated recognition mechanisms. In contrast, preincubation of mi
croglia with interleukin-4 (IL-4) inhibited the uptake of apoptotic cells,
whereas tumor-necrosis factor-alpha (TNF-alpha) and transforming growth fac
tor-beta (TGF-beta) did not alter phagocytosis. Phagocytic clearance of apo
ptotic inflammatory cells by microglia may be an important mechanism for th
e termination of autoimmune inflammation in the CNS. Augmentation of microg
lial phagocytosis by the Th-1-type cytokine IFN-gamma suggests a feedback m
echanism for the accelerated clearance of the inflammatory infiltrate in th
e CNS. GLIA 33:87-95, 2001. (C) 2001 Wiley-Liss, Inc.